DNA
Price
$7.63
Change
-$0.12 (-1.55%)
Updated
Nov 4 closing price
6 days until earnings call
ZURA
Price
$4.37
Change
-$0.03 (-0.68%)
Updated
Nov 4 closing price
Ad is loading...

DNA vs ZURA

Header iconDNA vs ZURA Comparison
Open Charts DNA vs ZURABanner chart's image
Ginkgo Bioworks Holdings
Price$7.63
Change-$0.12 (-1.55%)
Volume$687.92K
CapitalizationN/A
Zura Bio
Price$4.37
Change-$0.03 (-0.68%)
Volume$261.64K
CapitalizationN/A
View a ticker or compare two or three
DNA vs ZURA Comparison Chart
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNA vs. ZURA commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Buy and ZURA is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (DNA: $7.63 vs. ZURA: $4.38)
Brand notoriety: DNA and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 54% vs. ZURA: 48%
Market capitalization -- DNA: $424.04M vs. ZURA: $279.33M
DNA [@Biotechnology] is valued at $424.04M. ZURA’s [@Biotechnology] market capitalization is $279.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than DNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 6 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 6 bullish, 4 bearish.
  • ZURA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ZURA.

Price Growth

DNA (@Biotechnology) experienced а -7.74% price change this week, while ZURA (@Biotechnology) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.74%. For the same industry, the average monthly price growth was +10.27%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

DNA is expected to report earnings on Nov 11, 2024.

ZURA is expected to report earnings on Mar 28, 2023.

Industries' Descriptions

@Biotechnology (-1.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($424M) has a higher market cap than ZURA($279M). ZURA YTD gains are higher at: -6.210 vs. DNA (-88.713). ZURA has higher annual earnings (EBITDA): -41.15M vs. DNA (-763.83M). DNA has more cash in the bank: 730M vs. ZURA (188M). DNA has higher revenues than ZURA: DNA (184M) vs ZURA (0).
DNAZURADNA / ZURA
Capitalization424M279M152%
EBITDA-763.83M-41.15M1,856%
Gain YTD-88.713-6.2101,429%
P/E RatioN/A7.68-
Revenue184M0-
Total Cash730M188M388%
Total Debt452MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DNAZURA
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
33%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
46%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
46%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
41%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
38%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
38%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
47%
View a ticker or compare two or three
Ad is loading...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSFCX23.600.06
+0.25%
Federated Hermes Clover Small Value C
GPGOX3.45N/A
N/A
Grandeur Peak Global Opportunities Inv
PRJBX46.73-0.12
-0.26%
PGIM Jennison Global Opportunities R2
LEGHX11.49-0.03
-0.26%
BrandywineGLOBAL - Small Cap Value R
HCMWX20.88-0.08
-0.38%
HCM Dividend Sector Plus A1

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with HSTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then HSTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
N/A
HSTO - ZURA
38%
Loosely correlated
-1.18%
UBX - ZURA
31%
Poorly correlated
-4.58%
DNA - ZURA
30%
Poorly correlated
-1.55%
NKTX - ZURA
28%
Poorly correlated
+1.25%
CGEM - ZURA
27%
Poorly correlated
+0.76%
More